Management of MIS-A secondary to COVID-19, inpatient

  1. Bamrah Morris S et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection – United Kingdon and United States, Marcy – August 2020. MMWR Morb Mortal Wkly Rep 2020;69(40):1450-1456. 
  2. Godfred-Cato S, Bryant B, Leung J, et al.; California MIS-C Response Team. COVID-19– associated multisystem inflammatory syndrome in children—United States, March–July 2020. MMWR Morb Mortal Wkly Rep 2020;69:1074–80. CrossRefexternal icon PubMedexternal icon 
  3. Belot A, Antona D, Renolleau S, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 2020;25:2001010. CrossRefexternal icon PubMedexternal icon
  1. Chau VQ, Giustino G, Mahmood K, et al. Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19. Circ Heart Fail 2020. CrossRefexternal icon PubMedexternal icon
  2. Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology clinical guidance for pediatric patients with multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 and hyperinflammation in COVID-19. version 1. Arthritis Rheumatol 2020. CrossRefexternal icon PubMedexternal icon 
  3. CDC. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). Atlanta, GA: US Department of Health and Human Services, CDC; 2020.